✦ LIBER ✦

Relationship Between Body Mass Index and Serum Testosterone Concentration in Patients Receiving Luteinizing Hormone-releasing Hormone Agonist Therapy for Prostate Cancer

✍ Scribed by van der Sluis, Tim M.; van Moorselaar, R. Jeroen A.; Meuleman, Eric J.H.; ter Haar, Ronald W.; Bui, Hong N.; Heijboer, Annemieke C.; Vis, André N.

Book ID: 123089509
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 201 KB
Volume: 81
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2013.01.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

719 SERUM CONCENTRATION OF TESTOSTERONE

719 SERUM CONCENTRATION OF TESTOSTERONE MEASURED BY ISOTOPE DILUTION-LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (ID-LC-MS/MS) IN MEN AFTER BILATERAL ORCHIECTOMY OR LUTEINIZING HORMONE RELEASING HORMONE (LHRH) AGONIST THERAPY

✍ van der Sluis, Tim; Bui, Hong; Heijboer, Annemieke; Meuleman, Eric; van Moorsela 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 45 KB

Complementary therapies for reducing the

Complementary therapies for reducing the risk of osteoporosis in patients receiving luteinizing hormone-releasing hormone treatment/orchiectomy for prostate cancer: a review and assessment of the need for more research

✍ Mark A Moyad 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB

RTOG Protocol 05-18: A Phase III Randomi

RTOG Protocol 05-18: A Phase III Randomized Trial to Evaluate the Efficacy of Zoledronic Acid for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy (RT) and Long-term Luteinizing Hormone-releasing Hormone (LHRH) Agonist for High-grade and/or Locally Advanced Prostate Cancer

✍ Lawton, C.A.; Shook, S.; Smith, M.; Tripp, P.; Shah, A.B.; Martin, A.; Kim, H.E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB